CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +875 | $10.21 | $9K | 875 |
| 2024-07-01 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −875 | $18.01 | $16K | 0 |
| 2024-07-01 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −875 | 79,623 | ||
| 2024-06-24 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +9,260 | $10.21 | $95K | 9,260 |
| 2024-06-24 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −9,260 | $18.19 | $168K | 0 |
| 2024-06-24 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,260 | 80,498 | ||
| 2024-06-20 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2024-06-20 | HENSON HEIDI Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2024-06-20 | KEATING LAURIE Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2024-06-20 | Resnick Joshua Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2024-06-20 | Ashton Christopher Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2024-06-20 | Mayer Howard Director | Grant or award · Stock Option (Right to Buy) | +8,667 | 8,667 | ||
| 2024-06-20 | Dable Habib J Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2024-06-12 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +1,086 | $10.21 | $11K | 1,086 |
| 2024-06-12 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −1,086 | $18.06 | $20K | 0 |
| 2024-06-12 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,086 | 89,758 | ||
| 2024-06-11 | Mellion Michelle L Chief Medical Officer | Option exercise 10b5-1 | +500 | $10.21 | $5K | 500 |
| 2024-06-11 | Mellion Michelle L Chief Medical Officer | Sale 10b5-1 | −500 | $18.04 | $9K | 0 |
| 2024-06-11 | Mellion Michelle L Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −500 | 90,844 | ||
| 2024-06-06 | Mellion Michelle L SVP, Clinical Development | Option exercise 10b5-1 | +1,411 | $10.21 | $14K | 1,411 |
Page 6 of 11 · 211 trades